Vincenza D. F.
- Country
- Italy
- Department
- Ematologia
Research Overview
Data & Insights
Has run more than one trial at 0 of 11 partner sites.
Specializations
Hematologic Malignancies
Focus on blood‑related cancers and disorders.
- Acute Myeloid Leukemia (FLT3)
- Chronic Lymphocytic Leukemia
- Myelodysplastic Syndromes
- Myelofibrosis
- Lymphomas (Diffuse Large B‑Cell, Follicular, Mantle Cell, Marginal Zone)
Clinical work emphasizes risk stratification and novel targeted agents for these conditions.
Thoracic Oncology
Investigation of malignant diseases of the lung and pleura.
- Non‑Small Cell Lung Cancer (ALK‑positive, EGFR‑mutated, KRAS‑G12C, ROS1‑positive)
- Small‑Cell Lung Cancer
- Pleural Mesothelioma
- Lung Adenocarcinoma
- Squamous Cell Lung Cancer
Emphasis on molecularly driven therapies and immuno‑oncology approaches.
Gynecologic & Urologic Oncology
Research on cancers of the female reproductive tract and urinary system.
- Ovarian Cancer
- Endometrial Cancer
- Fallopian Tube Cancer
- Bladder Cancer (Muscle‑Invasive, Non‑Muscle‑Invasive)
- Urothelial Carcinoma
Includes studies of targeted HER2‑positive disease and immunotherapy combinations.
Melanoma & Skin Cancer
Dedicated to cutaneous and ocular melanomas and related skin malignancies.
- Advanced Melanoma
- Uveal Melanoma
- Cutaneous Melanoma
- Merkel Cell Carcinoma
- High‑Risk Resected Melanoma
Focuses on adjuvant and metastatic settings with checkpoint inhibition.
Molecular & Targeted Therapeutics
Exploration of biomarkers and targeted pathways across tumor types.
- FLT3 mutation
- ALK rearrangement
- ROS1 alteration
- HER2‑low expression
- KRAS G12C variant
- JAK2V617F positivity
- B7‑H4 selection
- PD‑L1 expression
- c‑Met overexpression
Supports precision medicine strategies linking genotype to therapeutic choice.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.